UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis

The oncologist (Dayton, Ohio), 2009-01, Vol.14 (1), p.70-76

2009

Volltextzugriff (PDF)

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib

Radiology, 2012-05, Vol.263 (2), p.590

2012

Volltextzugriff (PDF)

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

Acta oncologica, 2011-06, Vol.50 (5), p.700-710

2011

Volltextzugriff (PDF)

Breast Cancer Subtypes in Patients Aged 70 Years and Older

Cancer investigation, 2016-05, Vol.34 (5), p.197-204

2016

Volltextzugriff (PDF)

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

Blood, 2000-03, Vol.95 (6), p.1925-1930

2000

Volltextzugriff (PDF)

Luminal A and Luminal B subtypes in patients with breast cancer 65 years of age and older

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.549-549

2013

Volltextzugriff (PDF)

Tumor characteristics and recurrence patterns in triple negative breast cancer: A comparison between younger (<65) and elderly (⩾65) patients

European journal of cancer (1990), 2012-11, Vol.48 (16), p.2962-2968

2012

Volltextzugriff (PDF)

Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma

Journal of clinical oncology, 2000-02, Vol.18 (4), p.804-812

2000

Volltextzugriff (PDF)

The impact of estrogen depletion by aromatase inhibitors on adiponectin serum levels in postmenopausal patients with breast cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e11601-e11601

2013

Volltextzugriff (PDF)

Altered Epigenetic Regulation of Immune and Repair Processes in Interstitial Lung Disease

Konigsberg, Iain Robert

2021

Volltextzugriff (PDF)

Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.514-514

2012

Volltextzugriff (PDF)

Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods

Cancer letters, 2010-07, Vol.293 (1), p.117-123

2010

Volltextzugriff (PDF)

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

Investigational new drugs, 2019-02, Vol.37 (1), p.127-138

2019

Volltextzugriff (PDF)

Deletions of the p53 gene in multiple myeloma / Reply

British journal of haematology, 2000-03, Vol.108 (4), p.886

2000

Volltextzugriff (PDF)

The nature of the cell in multiple myeloma / Aughors' reply

The American journal of pathology, 1999-09, Vol.155 (3), p.1005

1999

Volltextzugriff (PDF)

Impact of AdipoR1 expression on breast cancer development

Gynecologic oncology, 2010-04, Vol.117 (1), p.134-138

2010

Volltextzugriff (PDF)

Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.577-577

2014

Volltextzugriff (PDF)

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

Radiology and oncology, 2014-06, Vol.48 (2), p.184-188

2014

Volltextzugriff (PDF)

How transferable are recommendations of the era of treating conventionally defined breast cancer for the era of molecularly characterised breast cancer?

Gland surgery, 2012-11, Vol.1 (3), p.156-158

2012

Volltextzugriff (PDF)

Prognostic Assessment and Adjuvant Treatment Strategies Within Early-Stage, Sporadic Triple Negative Breast Cancer Patients

Cancer investigation, 2011-02, Vol.29 (2), p.180-186

2011

Volltextzugriff (PDF)

Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients

Oncology, 2011-01, Vol.81 (5-6), p.359-364

2011

Volltextzugriff (PDF)

Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer

Journal of receptors and signal transduction, 2011-04, Vol.31 (2), p.180-187

2011

Volltextzugriff (PDF)

Cell Cycle Dysregulation Influences Survival in High Risk Breast Cancer Patients

Cancer investigation, 2008-01, Vol.26 (7), p.734-740

2008

Volltextzugriff (PDF)

Expression of the Lung Resistance Protein Predicts Poor Outcome in Patients with Multiple Myeloma

Clinical cancer research, 1999-09, Vol.5 (9), p.2426-2430

1999

Volltextzugriff (PDF)

Deletions Of The p53 Gene In Multiple Myeloma

British journal of haematology, 2000-03, Vol.108 (4), p.886-886

2000

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(62)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

Breast Cancer Subtypes in Patients Aged 70 Years and Older

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

Luminal A and Luminal B subtypes in patients with breast cancer 65 years of age and older

Tumor characteristics and recurrence patterns in triple negative breast cancer: A comparison between younger (<65) and elderly (⩾65) patients

Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma

The impact of estrogen depletion by aromatase inhibitors on adiponectin serum levels in postmenopausal patients with breast cancer

Altered Epigenetic Regulation of Immune and Repair Processes in Interstitial Lung Disease

Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial

Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

Deletions of the p53 gene in multiple myeloma / Reply

The nature of the cell in multiple myeloma / Aughors' reply

Impact of AdipoR1 expression on breast cancer development

Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial

Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

How transferable are recommendations of the era of treating conventionally defined breast cancer for the era of molecularly characterised breast cancer?

Prognostic Assessment and Adjuvant Treatment Strategies Within Early-Stage, Sporadic Triple Negative Breast Cancer Patients

Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients

Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer

Cell Cycle Dysregulation Influences Survival in High Risk Breast Cancer Patients

Expression of the Lung Resistance Protein Predicts Poor Outcome in Patients with Multiple Myeloma

Deletions Of The p53 Gene In Multiple Myeloma

Suchergebnisse filtern